[Experimental study on the pharmacology of a beta-adrenolytic agent: H 56-28 alprenolol. Studies with a special regard to the cardiovascular system, tracheal, gastric, intestinal, splenic and deferent muscles].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D004983:Ethanolamines / Q000494:pharmacology; D006168:Guinea Pigs; D007422:Intestines / Q000187:drug effects; D008297:Male; D009132:Muscles / Q000187:drug effects; D010636:Phenols / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013085:Spermatic Cord / Q000187:drug effects; D013154:Spleen / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D014132:Trachea / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D004983:Ethanolamines; D010636:Phenols; D013565:Sympatholytics; D011433:Propranolol
Contributo sperimentale alla farmacologia di un beta-adrenolitico: l'H 56-28 o alprenololo. Indagini con particolare riguardo all'apparato cardiovascolare e alle muscolture tracheael, gastrica, intestinale, uterina, splenica e deferenziale.